A relativity concept in mesenchymal stromal cell manufacturing

Area of Science:

• Cell Biology
• Regenerative Medicine
• Biotechnology

Background:

• Mesenchymal stromal cells (MSCs) show therapeutic potential but are heterogeneous.
• Donor, harvest site, and culture conditions influence MSC phenotype and function.
• Producing standardized MSC batches for scalable manufacturing remains a challenge.

Purpose of the Study:

• To review MSC culture methods and functional assessments.
• To propose a roadmap for refining MSC manufacturing systems for clinical use.
• To address the feasibility of standardized MSC therapeutics.

Main Methods:

• Literature review of MSC culture techniques and functional assays.
• Analysis of MSC heterogeneity and its impact on manufacturing.
• Development of a strategic approach for MSC production.

Main Results:

• Current MSC manufacturing faces challenges due to inherent cell variability.
• A unique standard for all MSC production is not yet scientifically supported.
• Standardized characterization across different MSC batches is crucial.

Conclusions:

• Efforts should prioritize standardizing MSC characterization methods over a single manufacturing standard.
• Combining characterization data with clinical insights will define manufacturing controls.
• Validated in-process controls and release criteria are essential for predicting MSC potency and efficacy.